This site is intended for health professionals only

Home / News / PSNC secures £15m cat M reimbursement price increase

PSNC secures £15m cat M reimbursement price increase


By Léa Legraien
Reporter

19 Jul 2018

 Category M reimbursement prices will increase by £15m per month from August, the Pharmaceutical Negotiating Services Committee (PSNC) has announced.

PSNC revealed today (19 July) that the current category M clawbacks – equating to a 35p reduction per item on drug tariff prices – will end next month, as confirmed by the Department of Health and Social Care (DHSC).

The news comes after PSNC held several meetings with the DHSC, pointing out the impacts of the reductions on contractors’ cashflow issues caused by clawbacks, it said.

 

‘Recovering excess margin’

 

In August 2017, PSNC revealed that reimbursement prices had been reduced by £15m a month, leading to a reduction of 17-18p per item on drug tariff prices until August 2018. At the time, the DHSC imposed these reductions to recover estimated excess margin delivered to pharmacies in 2015/16 and 2016/17, PSNC said.

This was followed by a further 17p reduction per item this month.

 

‘Very positive’ decision

 

‘PSNC director of pharmacy funding Mike Dent said: ‘The decision to cease margin recovery in the short-term in light of PSNC’s representations about contractors’ cash flow is very positive and reflective of the collaborative relationship that we are trying to rebuild with the DHSC.

‘PSNC will be working, through the negotiations on funding and in discussions with the DHSC to get the best possible deal for contractors and to ensure that any future mechanisms to correct margin delivery are as manageable as possible in terms of cash flow.’

The prices will apply to August and September, with October prices based on a new drug tariff, which is ‘unknown at the moment’, PSNC said.

PSNC highlighted that ‘underlying category M prices will continue to be based on manufacturers’ data, so prices will still reflect the lower purchase prices that led to the additional reduction in prices seen in the July drug tariff’.


Want news like this straight to your inbox?


Latest News

Diverse pharmacists needed in senior public health roles, says MP
There needs to be more diverse pharmacists in senior roles across national public health bodies, hospital administration and wider government to achieve equality in...
Anti-smoking drug recalled over nitrosamine concerns
The smoking cessation drug, Champix, has been recalled over concerns the product may contain elevated...
Pharmacies on track to deliver record 3 million flu vaccines
Community pharmacies in England could be on track to administer a record 3 million flu...